Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes.

Few trials of glucose-lowering drugs or strategies in people with type 2 diabetes have investigated cardiovascular outcomes, even though most patients die from cardiovascular causes despite the beneficial effects of lipid-reducing and blood pressure-lowering treatments. The evidence-based reduction...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: Holman, R, Sourij, H, Califf, R
Формат: Journal article
Хэл сонгох:English
Хэвлэсэн: Lancet 2014